نتایج جستجو برای: nortriptyline

تعداد نتایج: 436  

Journal: :Chest 2002
Célia Lidia da Costa Riad Naim Younes Maria Teresa Cruz Lourenço

OBJECTIVE The administration of antidepressant drugs was shown to positively affect the rate of smoking cessation. This study evaluates the efficacy of nortriptyline in an antismoking program. METHODS A possible randomized double-blind study that included 144 patients who were randomized to receive nortriptyline, 75 mg/d (68 patients), or placebo (76 patients), during 6 consecutive weeks. All...

Journal: :The Journal of pharmacology and experimental therapeutics 2007
Suwen Su Yukihiro Ohno Christoph Lossin Hiroshi Hibino Atsushi Inanobe Yoshihisa Kurachi

The inwardly rectifying K(+) (Kir) channel Kir4.1 is responsible for astroglial K(+) buffering. We examined the effects of nortriptyline, a tricyclic antidepressant (TCA), on Kir4.1 channel currents heterologously expressed in HEK293T cells, using a whole-cell patch-clamp technique. Nortriptyline (3-300 microM) reversibly inhibited Kir4.1 currents in a concentration-dependent manner, whereas it...

Journal: :Pulmonary pharmacology & therapeutics 2006
Fábio M Haggsträm José M Chatkin Eliana Sussenbach-Vaz Débora H Cesari Claudia F Fam Carlos C Fritscher

PURPOSE AND METHODS Cognitive behavior therapy (CBT) constitutes the basis of smoking cessation programs. Quitting rates are usually increased by the concomitant use of CBT and pharmacotherapy. There are studies showing the efficacy of bupropion and nortriptyline compared to placebo, but there is just one published comparison between these drugs, unfortunately with low power to detect significa...

Journal: :Pharmacological reports : PR 2010
Bożena Gabryel Anna Bielecka Anna Stolecka Jacek Bernacki Józef Langfort

The protective potential of nortriptyline has been reported in a few experimental models of brain ischemia, both in vivo and in vitro. However, the detailed molecular mechanisms of the protective action of the drug are still unresolved. The aim of the present study was to determine whether treatment with low or medium concentrations of nortriptyline (0.1-10 μM) might have an effect on cPLA₂ pro...

Journal: :The American journal of psychiatry 1992
C F Reynolds E Frank J M Perel S D Imber C Cornes R K Morycz S Mazumdar M D Miller B G Pollock A H Rifai

OBJECTIVE The authors examined the rate of response to the combination of nortriptyline and interpersonal psychotherapy for acute and continuation treatment of elderly patients with recurrent major depression. METHOD The subjects were 73 elderly patients, 61 of whom completed treatment. Nortriptyline steady-state blood levels were maintained at 80-120 ng/ml, and interpersonal psychotherapy wa...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 1997
O V Olesen K Linnet

The metabolism of nortriptyline was studied in vitro using cDNA-expressed human cytochrome P450 isozymes 1A2, 3A4, 2C19, and 2D6, CYP2D6 was the sole isozyme mediating hydroxylation of nortriptyline, the quantitatively most important metabolic pathway, and only (E)-10-OH-nortriptyline was formed. CYP2D6, 2C19, and 1A2, mentioned in decreasing order of significance, mediated the demethylation re...

Journal: :Archives of general psychiatry 1998
S M Hall V I Reus R F Muñoz K L Sees G Humfleet D T Hartz S Frederick E Triffleman

BACKGROUND A history of major depressive disorder (MDD) predicts failure to quit smoking. We determined the effect of nortriptyline hydrochloride and cognitive-behavioral therapy on smoking treatment outcome in smokers with a history of MDD. The study also addressed the effects of diagnosis and treatment condition on dysphoria after quitting smoking and the effects of dysphoria on abstinence. ...

Background: The negative symptoms of schizophrenia remain a major clinical challenge. Nortriptyline is a serotonin and noradrenalin reuptake inhibitor and belongs to secondary amine tricycles. The aim of this study is to evaluate the effect of nortriptyline on the negative symptoms of schizophrenia. Methods: This study is a six-week randomized placebo-control trial of nortriptyline or placebo a...

2011
Nicolas Mercado Yasuo To Kazuhiro Ito Peter J. Barnes

Corticosteroid insensitivity represents a major barrier to the treatment of chronic obstructive pulmonary disease (COPD) and severe asthma. It is caused by oxidative stress, leading to reduced histone deacetylase-2 (HDAC2) function through activation of phosphoinositide-3-kinase(PI3K ). The tricyclic antidepressant nortriptyline has been identified in high-throughput screens as an agent that in...

Journal: :Journal of advances in medical and biomedical research 2022

The Effect of Sertreline Versus Nortriptyline on Quality Life and Depression After Stroke:A Randomized Double-Blind Controlled Study

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید